Aspartate beta-hydroxylase is a prognostic factor in gallbladder cancer with the function of promoting tumorigenesis and chemoresistance
ASPH plays a role in promoting the development of gallbladder cancer and resistance to chemotherapeutic agents, rendering it a promising target for therapeutic interventions. Active therapeutic compounds targeted on ASPH can be identified among the active ingredients present in traditional Chinese medicine.
Authors
- Huang Yun-peng
- Li Xiong (ORCID: https://orcid.org/0000-0002-5570-0229)
- Yuan Luo
- Yongxiang Wang (ORCID: https://orcid.org/0000-0002-2003-6006)
- Yu Wen (ORCID: https://orcid.org/0000-0002-4413-2115)
Institutions
- Central South University (CN)
- Second Xiangya Hospital of Central South University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-03-05
- DOI
- https://doi.org/10.3389/fendo.2025.1452345
- Citations
- 4
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 3.75